1.42
price up icon0.71%   0.01
after-market Handel nachbörslich: 1.42
loading

Coherus Oncology Inc Aktie (CHRS) Neueste Nachrichten

pulisher
Dec 24, 2025

Coherus Oncology (NASDAQ:CHRS) Stock Crosses Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat

Dec 24, 2025
pulisher
Dec 23, 2025

Coherus Oncology: A Two-Pronged March With Mid-2026 Implications (CHRS) - Seeking Alpha

Dec 23, 2025
pulisher
Dec 22, 2025

Coherus Oncology, Inc.(NasdaqGM: CHRS) added to NASDAQ Biotechnology Index - marketscreener.com

Dec 22, 2025
pulisher
Dec 21, 2025

Coherus Oncology (CHRS) price target increased by 13.33% to 5.78 - MSN

Dec 21, 2025
pulisher
Dec 21, 2025

Coherus Oncology (CHRS) Price Target Increased by 13.33% to 5.78 - Nasdaq

Dec 21, 2025
pulisher
Dec 19, 2025

Aug Shorts: How Coherus Oncology Inc. (8C5) stock valuation compares with sectorQuarterly Portfolio Review & AI Driven Stock Price Forecasts - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

CEO Moves: How Coherus Oncology Inc. (8C5) stock valuation compares with sectorMarket Weekly Review & Risk Controlled Stock Pick Alerts - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

Support Test: Can Coherus Oncology Inc. (8C5) stock survive global slowdownJuly 2025 Macro Moves & Smart Swing Trading Techniques - Улправда

Dec 19, 2025
pulisher
Dec 18, 2025

Will Coherus Oncology Inc. (8C5) stock deliver stable dividends2025 Dividend Review & Breakout Confirmation Alerts - Улправда

Dec 18, 2025
pulisher
Dec 18, 2025

Can Coherus Oncology Inc. (8C5) stock survive global slowdownJuly 2025 Institutional & Capital Efficient Trading Techniques - Улправда

Dec 18, 2025
pulisher
Dec 17, 2025

CHRS: 2026 will be pivotal with major data readouts for novel immuno-oncology therapies - TradingView — Track All Markets

Dec 17, 2025
pulisher
Dec 16, 2025

Coherus Oncology (NASDAQ:CHRS) Stock Price Crosses Above 200 Day Moving AverageTime to Sell? - MarketBeat

Dec 16, 2025
pulisher
Dec 15, 2025

Coherus Oncology Earnings Notes - Trefis

Dec 15, 2025
pulisher
Dec 09, 2025

LOQTORZI plus chemotherapy shows 31-month survival benefit in cancer study - Investing.com Australia

Dec 09, 2025
pulisher
Dec 08, 2025

Coherus BioSciences stock jumps after positive cancer drug survival data By Investing.com - Investing.com UK

Dec 08, 2025
pulisher
Dec 08, 2025

Coherus BioSciences stock jumps after positive cancer drug survival data - Investing.com

Dec 08, 2025
pulisher
Dec 08, 2025

Coherus Announces Six-Year JUPITER-02 Follow-up Results Showing LOQTORZI® plus Chemotherapy Nearly Doubles Median Overall Survival in Nasopharyngeal Carcinoma - The Manila Times

Dec 08, 2025
pulisher
Dec 06, 2025

Coherus Oncology (CHRS) price target decreased by 11.77% to 5.10 - MSN

Dec 06, 2025
pulisher
Dec 05, 2025

Why Coherus Oncology Inc. (8C5) stock stays on top picksTrade Risk Summary & Daily Technical Forecast Reports - Newser

Dec 05, 2025
pulisher
Dec 04, 2025

Why global investors buy Coherus Oncology Inc. (8C5) stockJuly 2025 Earnings & Expert Verified Movement Alerts - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Does Coherus Oncology Inc. (8C5) stock trade below intrinsic valueMarket Volume Summary & Community Consensus Stock Picks - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Why Coherus Oncology Inc. (8C5) stock could rally strongly2025 Trading Volume Trends & Free Safe Entry Trade Signal Reports - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Can Coherus Oncology Inc. (8C5) stock sustain free cash flow2025 Macro Impact & AI Enhanced Trading Alerts - Newser

Dec 04, 2025
pulisher
Dec 03, 2025

Coherus Oncology, Inc. (NASDAQ:CHRS) Looks Inexpensive After Falling 28% But Perhaps Not Attractive Enough - 富途牛牛

Dec 03, 2025
pulisher
Dec 03, 2025

Can Coherus Oncology Inc. (8C5) stock hold up in economic slowdownTrade Risk Assessment & Fast Gain Stock Tips - Newser

Dec 03, 2025
pulisher
Dec 03, 2025

How strong is Coherus Oncology Inc. (8C5) stock earnings growthAnalyst Downgrade & Safe Entry Zone Identification - Newser

Dec 03, 2025
pulisher
Dec 02, 2025

Coherus Oncology (CHRS) Stock Analysis Report | Ratings, Financials & Performance - Benzinga

Dec 02, 2025
pulisher
Nov 26, 2025

Is Coherus Oncology Inc 8C5 a good long term investmentEconomic Impact on Stocks & Build Wealth Brick by Brick With Us - earlytimes.in

Nov 26, 2025
pulisher
Nov 23, 2025

What analysts say about Coherus Oncology Inc 8C5 stockGap Up/Gap Down Analysis & Outstanding Profit Strategies - earlytimes.in

Nov 23, 2025
pulisher
Nov 23, 2025

Coherus Oncology, Inc. (NASDAQ:CHRS) Given Average Rating of "Hold" by Brokerages - MarketBeat

Nov 23, 2025
pulisher
Nov 21, 2025

Will Coherus Oncology Inc. (8C5) stock top growth indexesJuly 2025 Sector Moves & Daily Volume Surge Signals - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Will Coherus Oncology Inc. (8C5) stock outperform value peersPortfolio Update Summary & High Conviction Buy Zone Alerts - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Can Coherus Oncology Inc. (8C5) stock attract analyst upgradesJuly 2025 Selloffs & Risk Managed Investment Signals - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

Will Coherus Oncology Inc. (8C5) stock benefit from infrastructure billOil Prices & Technical Confirmation Trade Alerts - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

How Coherus Oncology Inc. (8C5) stock reacts to Fed tighteningWeekly Trade Analysis & Consistent Growth Stock Picks - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Coherus Oncology Inc. (8C5) stock included in top ETFs2025 Top Decliners & AI Forecasted Entry and Exit Points - newser.com

Nov 19, 2025
$38.64
price down icon 0.90%
$30.80
price down icon 2.19%
$98.77
price down icon 0.14%
$95.20
price down icon 0.08%
biotechnology ONC
$303.81
price down icon 0.30%
$174.04
price down icon 0.03%
Kapitalisierung:     |  Volumen (24h):